Evolving features in type 3 Gaucher disease on long-term enzyme replacement therapy

被引：5
|
作者：
Elstein, Deborah [1 ]
Abrahamov, Ayala
Altarescu, Gheona
Zimran, Ari
机构：
[1] Shaare Zedek Med Ctr, Gaucher Clin, IL-91031 Jerusalem, Israel
来源：
BLOOD CELLS MOLECULES AND DISEASES | 2013年 / 50卷 / 02期
关键词：
D O I：
10.1016/j.bcmd.2012.09.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [1] Individualization of long-term enzyme replacement therapy for Gaucher disease
    Andersson, HC
    Charrow, J
    Kaplan, P
    Mistry, P
    Pastores, GM
    Prakesh-Cheng, A
    Rosenbloom, BE
    Scott, CR
    Wappner, RS
    Weinreb, NJ
    GENETICS IN MEDICINE, 2005, 7 (02) : 105 - 110
  • [2] LONG-TERM EFFECTS OF ENZYMATIC REPLACEMENT THERAPY IN GAUCHER TYPE 3 DISEASE
    Bertin, N.
    Deroma, L.
    Ciana, G.
    Sechi, A.
    Dardis, A.
    Deganuto, M.
    Malini, E.
    Bembi, B.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S100 - S100
  • [3] Individualized long-term enzyme therapy for Gaucher disease type 1 in Slovenia
    Benedik-Dolnicar, Majda
    Kitanovski, Lidija
    PEDIATRICS INTERNATIONAL, 2011, 53 (06) : 1018 - 1022
  • [4] Long term effects of enzyme replacement therapy in an Italian cohort of type 3 Gaucher patients
    Sechi, Annalisa
    Deroma, Laura
    Dardis, Andrea
    Ciana, Giovanni
    Bertin, Nicole
    Concolino, Daniela
    Linari, Silvia
    Perria, Chiara
    Bembi, Bruno
    MOLECULAR GENETICS AND METABOLISM, 2014, 113 (03) : 213 - 218
  • [5] Comprehensive and long-term outcomes of enzyme replacement therapy followed by stem cell transplantation in children with Gaucher disease type 1 and 3
    Anurathapan, Usanarat
    Tim-Aroon, Thipwimol
    Zhang, Wujuan
    Sanpote, Watinee
    Wongrungsri, Siranee
    Khunin, Nitcha
    Chutipongtanate, Somchai
    Chirdkiatgumchai, Vilawan
    Ngiwsara, Lukana
    Jaovisidha, Suphaneewan
    Khongkraparn, Arthaporn
    Pakakasama, Samart
    Svasti, Jisnuson
    Setchell, Kenneth D. R.
    Wattanasirichaigoon, Duangrurdee
    Hongeng, Suradej
    PEDIATRIC BLOOD & CANCER, 2023, 70 (03)
  • [6] CLINICAL OUTCOMES OF LONG-TERM (8 YEARS) ENZYME REPLACEMENT THERAPY IN 884 CHILDREN WITH TYPE 1 GAUCHER DISEASE
    Andersson, H.
    Kaplan, P.
    Kacena, K.
    Yee, J.
    CLINICAL THERAPEUTICS, 2008, 30 : S101 - S102
  • [7] Long-term visceral and hematologic outcomes of enzyme replacement therapy in a pediatric cohort of type 1 and type 3 Gaucher disease: A single center experience
    Gumus, Ersin
    Karhan, Asuman Nur
    Demir, Hulya
    Ozen, Hasan
    Temizel, Inci Nur Saltik
    Emre, Serap Dokmeci
    Yuce, Aysel
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S65 - S65
  • [8] A prospective study of enzyme replacement therapy in type 3 Gaucher disease
    Schiffmann, R
    Parker, CC
    Scott, LJC
    DeGraba, T
    Brady, RO
    Barton, NW
    NEUROLOGY, 1996, 46 (02) : 1107 - 1107
  • [9] Enzyme replacement therapy in type 2 Gaucher disease
    Tournay, A
    Parker, C
    Schiffman, R
    Brady, R
    Barton, N
    NEUROLOGY, 1996, 46 (02) : 1106 - 1106
  • [10] Enzyme replacement therapy in type III Gaucher disease
    Tylki-Szymanska, A
    Czartoryska, B
    JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (02) : 203 - 204
12345